Start main page content

Regular physical activity before cancer diagnosis may lower progression and death risks

- Wits University

Even relatively low levels of physical activity may be advantageous, findings from a study led by Wits Sport and Health (WiSH) shows.

Regular physical activity before a cancer diagnosis may lower the risks of both disease progression and death, suggests research published online today in the British Journal of Sports Medicine (BJSP).

Man on a treadmill. Image from Pexels

And even relatively low levels of physical activity may be advantageous, the findings indicate.

There is compelling evidence that physical activity has a key part to play in lowering the risk of death from cancer, but the evidence is not as conclusive for its role in disease progression, explain the researchers.

To explore this further, they analysed anonymised data from the Discovery Health Medical Scheme (DHMS), linked to the Vitality health promotion programme. The DHMS is the largest open medical plan in South Africa, covering approximately 2.8 million beneficiaries.

All Vitality programme participants are rewarded for adopting healthy lifestyle behaviours, earning points for physical activity, recorded by activity trackers, logged gym attendance, or registered participation in organised fitness activities. Activity type, frequency, duration, and intensity are recorded and translated into weekly minutes of exercise.

This research published in BJSP is novel in several ways:

  • It represents one of the largest datasets globally that investigates the association between cancer prognosis and physical activity
  • The cohort is the first to be studied outside of western medical centres/Global North
  • The research represents a collaboration between a private health insurer (Discovery Health Medical Scheme) and academic institutions in South Africa (Wits University) and Canada (University of Western Ontario)
  • Physical activity in the cancer patients was directly measured rather than self-reported.

Moreover, with cancers being diagnosed earlier and an increasing incidence, accessible interventions that may positively influence prognosis are more relevant than ever.

“Knowing that as little as 60 minutes of regular weekly exercise may reduce the likelihood of cancer progression by 27% and death by 47%, should encourage all doctors to use exercise as medicine,” says lead author Jon Patricios, Professor of Sports and Exercise Medicine at WiSH, Wits University. “Regular physical activity is the most powerful and accessible prescription we can give our patients. This study confirms the benefits of even relatively small amounts of physical activity, but we should encourage adherence to the WHO guidelines of 300 minutes per week of moderate intensity exercise for all of its well-described benefits.”

必博娱乐,比博娱乐网址 the study

In all, 28,248 Vitality programme members with stage 1 cancers, and comprehensive physical activity data for the year preceding diagnosis, were included in the study, which spanned the period 2007 to 2022.

Breast and prostate cancers were the most common cancers, comprising 44% of the study total.

The length of time between initial diagnosis and disease progression, death, or exit from the study ranged from 1 month to nearly 13 years.

Cancer did not progress in nearly two thirds of the total sample (65.5%), but in just over a third (34.5%) it did. And while 81% survived, 19% died before the end of the study. The average time to death was 20 months and the average time to progression was 7 months.

Levels of physical activity in the year before diagnosis were categorised as none recorded (17,457; 62% of participants); low, equal to 60 or fewer weekly minutes (3722;13%); and moderate to high, equal to 60 or more weekly minutes of moderate intensity physical activity (7069; 25%).

Key findings

After accounting for potentially influential factors, including age at diagnosis, sex, economic and social position, and co-existing conditions, rates of cancer progression and death from any cause were lower among those who were physically active in the year preceding their diagnosis.

The odds of disease progression were 16% lower for those who had engaged in low levels of physical activity in the preceding year than among those who had not recorded any physical activity, while the odds for those who had engaged in moderate to high levels were 27% lower.

Similarly, the odds of death from any cause were 33% lower among those who had engaged in low levels of physical activity compared with those who had not recorded any, and 47% lower for those who had managed moderate to high levels.

Two years on from diagnosis, the likelihood of no disease progression among those with no recorded physical activity in the year before diagnosis was 74%, compared with 78% and 80%, respectively, for those achieving low and moderate to high levels of physical activity.

While the likelihood of disease progression increased as time went on, it was still lower for those who had clocked up some level of physical activity in the year preceding their diagnosis. After 3 years, the likelihood of no disease progression was 71%, 75%, and 78%, respectively, for none, low, and moderate to high levels of physical activity. And after 5 years, it was 66%, 70%, and 73%, respectively.

Similar patterns were evident for death from any cause. Two years after diagnosis, the probability of survival among those with no documented physical activity in the year preceding diagnosis was 91% compared with 94% and 95%, respectively, among those who had recorded low and moderate to high levels.

The equivalent probabilities of survival 3 years after diagnosis were 88%, 92%, and 94%, respectively, and 84%, 90%, and 91%, respectively, after 5 years.

This is an observational study, and as such, cannot establish cause and effect. And the researchers acknowledge that they were not able to account for other potentially influential factors, such as smoking and alcohol consumption, while the data on weight (BMI) were incomplete.

But there are several plausible biological explanations for the findings, they suggest, chief among which is the way in which physical activity strengthens immunity by increasing numbers of natural killer cells, lymphocytes, neutrophils, and eosinophils.

Physical activity may also lower the progression risk of hormone sensitive cancers, such as breast and prostate cancers, by regulating oestrogen and testosterone levels, they add.

“Physical activity may be considered to confer substantial benefits in terms of progression and overall mortality to those diagnosed with cancer,” researchers note. “In a world where cancer continues to be a significant public health burden, the promotion of physical activity can yield important benefits regarding the progression of cancer as well as its prevention and management,” they conclude. 

Share